A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Laird Thermal Systems’ Nextreme™ NRC400 Performance Chiller Ensures Quality Resolution for Digital Microscopes

Environmentally friendly thermoelectric recirculating chiller with zero GWP ensures temperature stability and high-resolution images.

The advanced design of Laird Thermal Systems’ new thermoelectric-based Nextreme™ NRC400 Performance Chiller provides a highly reliable cooling solution for digital light microscope applications.

This next-generation recirculating chiller achieves 400 watts of cooling capacity and a temperature control stability to within ±0.05°C under steady-state conditions to ensure high-resolution images and long-life operation with zero global warming potential.

Digital light microscopes utilizing a CCD or CMOS sensor-based camera, such as those used in life science and biotechnology research, require precise temperature control to maintain high-quality image resolution. Digital microscopes contain several imaging sensors and field-programmable gate array (FPGA) semiconductors to enhance image quality and camera functionality. Because CCD and CMOS image resolution degrades as temperature increases, sensor temperatures of 18°C or lower may be required to allow for long exposures.

“It can be difficult to control the temperature in sophisticated analytical imaging instruments. Simple passive thermal solutions such as heat sinks and fans can radiate heat to surrounding electronics and elevate their temperatures,” says Andrew Dereka, Thermoelectrics Product Director at Laird Thermal Systems. “Thermoelectric-based recirculating chillers provide precise temperature control with low pulsation and efficiently route heat away from sensitive electronics, ensuring maximum image resolution.”

To achieve optimal digital microscope operating temperatures, refrigeration systems are required to cool imaging sensors below ambient temperatures. This isn’t possible with passive cooling technologies like liquid heat exchangers that cool slightly above ambient. Sensitive optoelectronic components in cameras need to be temperature controlled to a stability of ±0.05°C or better. Cooling laser optics and sensitive components also maximizes equipment uptime, reduces maintenance, and increases the mean time between failures (MTBF).

The Nextreme NRC400 Performance Chiller is a premium thermoelectric-based chiller utilizing high-performance Peltier coolers and heat exchanger technology. The chiller incorporates a brand-name pump with low pulsation assuring minimal noise to sensitive optoelectronics. Solid-state thermoelectric technology reduces the number of moving parts, minimizing maintenance requirements throughout the life of the product.

Other NRC400 features include an intuitive easy-to-use LCD touchscreen display that allows users to control temperature setpoints and alarm features, and a semi-closed system with a larger reservoir tank, requiring less refilling during operation and better temperature stability. Additionally, unlike traditional compressor-based systems, thermoelectric-based chillers are designed with portability in mind, which means that they can be easily moved around in the laboratory.

This product has been approved by UL for industrial lab use, reference UL 61010-1 and has CE marking. The NRC400 is RoHS-compliant and environmentally friendly as no harmful HFC refrigerants are used, resulting in zero global warming potential. It operates on a universal power supply, making it easy to source one part number for global use.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
“We are excited to present the first look at the safety and clinical activity of ELVN-001, which we believe supports the potential for ELVN-001 to address the limitations of the available active-site TKIs,” said Helen Collins, M.D., Chief Medical Officer of Enliven. “Across a wide dose range, ELVN-001 demonstrated activity in a heavily pre-treated patient population that includes post-asciminib patients, with a preliminary safety profile consistent with its highly selective design. Not only did all evaluable patients have improved or stable BCR::ABL1 transcript levels, but, importantly, 89% of all patients enrolled remain on study. We believe the initial data demonstrate the potential clinical utility of ELVN-001 for all types of patients, including those that are earlier in the treatment paradigm.”
The partnership is with Health-HavenRx ™, an online pharmacy platform. This partnership enables a new, convenient channel for patients to access POGO Automatic by using their health insurance on Intuity Medical’s e-commerce website at www.GoodtoPogo.com.

By using this website you agree to accept Medical Device News Magazine Privacy Policy